By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tokai Pharmaceuticals 

Boston  Massachusetts    U.S.A.
Phone: Fax:



Company News
Tokai Pharmaceuticals (TKAI) Announces Closing Of Initial Public Offering 9/24/2014 12:04:40 PM
Tokai Pharmaceuticals Announces Pricing Of Initial Public Offering 9/17/2014 9:19:42 AM
Tokai Pharmaceuticals Bags $97 Million For Prostate Cancer Drug In Upsized IPO 9/17/2014 7:38:06 AM
Tokai Pharmaceuticals Appoints Lee Kalowski As Chief Financial Officer 9/2/2014 11:17:46 AM
Tokai Pharmaceuticals Appoints Daniel T. Dransfield, Ph.D. As Vice President, Head Of Translational Medicine 8/27/2014 8:59:59 AM
Tokai Pharmaceuticals, Chasing The Field In Prostate Cancer, Files For $75 Million IPO 8/12/2014 7:23:11 AM
Tokai Pharmaceuticals Presents New Clinical Data For Galeterone Among Patients With Advanced Prostate Cancer At American Society of Clinical Oncology 2014 6/2/2014 10:49:18 AM
Updated Phase 2 Clinical Data On Tokai Pharmaceuticals’ Galeterone In Advanced Prostate Cancer To Be Presented At The 2014 American Society of Clinical Oncology Annual Meeting 5/16/2014 8:03:09 AM
Tokai Pharmaceuticals Appoints Khalid Mamlouk, Pharm.D. As Vice President, Head Of Medical Affairs 5/6/2014 8:01:07 AM
Tokai Pharmaceuticals Appoints Karen J. Ferrante, M.D. As Head Of R&D And Chief Medical Officer 4/15/2014 6:47:45 AM